Treace Medical Concepts, Inc. (TMCI) Tops Q2 EPS by 1c

Treace Medical Concepts, Inc. (NASDAQ: TMCI) reported Q2 EPS of ($0.28), $0.01 better than the analyst estimate of ($0.29). Revenue for the quarter came in at $47.39 million versus the consensus estimate of $47.08 million.

For earnings history and earnings-related data on Treace Medical Concepts, Inc. (TMCI) click here.

You May Also Be Interested In

• Freedom Broker Upgrades John B. Sanfilippo & Son, Inc. (JBSS) to Buy
• Bessent on bonds: buyback could be more than 4 billion - CNBC
• Popular stocks with increasing option volume: SPCX MSTR INTC MRNA WMT MU BABA COIN SOFI GOOGL PLTR